Previous 10 | Next 10 |
2023-11-08 07:01:17 ET More on Charles River Laboratories Charles River Laboratories: Diving Into The Lab (Rating Upgrade) Charles River Laboratories Q3 2023 Earnings Preview Charles River falls on Investor Day amid growth concerns Seeking Alpha’s Quan...
– Third-Quarter Revenue of $1.03 Billion – – Third-Quarter GAAP Earnings per Share of $1.69 and Non-GAAP Earnings per Share of $2.72 – – Updates 2023 Guidance – Charles River Laboratories International, Inc. (NYSE: CRL) today...
Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...
Charles River Laboratories International Inc. (CRL) is expected to report $2.35 for Q3 2023
2023-11-07 11:50:34 ET More on Charles River Laboratories Charles River Laboratories: Diving Into The Lab (Rating Upgrade) Charles River Laboratories International, Inc. (CRL) Q2 2023 Earnings Call Transcript Charles River falls on Investor Day amid growth concerns ...
2023-11-05 23:46:57 ET In the upcoming week of November, investors can anticipate a flurry of quarterly reports from major companies, promising significant market activity. Notable among them is Disney ( NYSE: DIS ), a household name set to disclose its financial performance. ...
2023-11-01 13:08:40 ET Shares of IQVIA Holdings ( NYSE: IQV ) reached the lowest level in over a year on Wednesday after the contract research firm lowered its full-year outlook with its Q3 2023 financials, dragging its rivals in the industry. Notable decliners include Inotiv ( ...
2023-10-30 12:28:25 ET More on Revvity Revvity: Recent Investments, Acquisitions, Not Pulling Economic Weight (Rating Downgrade) Revvity, Inc. (RVTY) Q2 2023 Earnings Call Transcript Revvity, Inc. 2023 Q2 - Results - Earnings Call Presentation Revvity misses ...
2023-10-24 19:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Charles River Laboratories International, Inc. (NYSE: CRL) today announced a new e-commerce ordering experience, offering clients real-time access into research model availability and pricing, as well as immediate order confirmation. The introduction of real-time ordering for Charles River’...
News, Short Squeeze, Breakout and More Instantly...
Charles River Laboratories International Inc. Company Name:
CRL Stock Symbol:
NYSE Market:
Charles River Laboratories International Inc. Website:
Lentiviral vector CDMO collaboration to support advanced cell therapies for hematological cancers Charles River Laboratories International, Inc. (NYSE: CRL) and the Gates Institute at the University of Colorado Anschutz Medical Campus today announced a lentiviral vector contract...
2024-06-18 18:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Leveraging CGT CDMO expertise to support T-cell immunotherapy clinical trial Charles River Laboratories International, Inc. (NYSE: CRL) and Captain T Cell, a spinoff from the renowned Max Delbrück Center Berlin, Germany, today announced a plasmid DNA and retrovirus vector productio...